This job has expired

You will need to login before you can apply for a job.

Senior Research Associate 1, Assay Strategy and Development, Translational Sciences

BioMarin Pharmaceutical Inc.
San Rafael, California
Start date
Dec 9, 2023

View more

Marketing, Regulatory, Science/R&D, Research
Required Education
Bachelors Degree
Position Type
Full time
Biotech Bay, Best Places to Work

Job Details

Who We Are

From research and discovery to post-market clinical development, our WWRD engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with genetic diseases.


The Assay Strategy and Development group within Translational Sciences develops methods for the detection of drugs, antibodies to therapeutics, and biomarkers in biological matrices to support projects through multiple stages of development. We are searching for a talented and highly motivated Senior Research Associate (SRA) to join a bioanalytical team that will be responsible for the generation of data to enable the successful development of pre-clinical and clinical programs. The candidate will be responsible for the development of assays for diverse modalities, which may include gene therapies, monoclonal antibodies, oligonucleotides, biologics, and small molecules. Candidates should be familiar with guidance documents for regulated sample testing and should have experience developing bioanalytical methods.

The successful candidate will participate in programs that range from exploratory in vitro and animal studies to non-clinical efficacy, safety studies, and clinical trials. You will be responsible for developing new methods, evaluating novel technologies, and conducting translational research internally at the BioMarin Research Center and externally in partnership with contract research organizations. This position offers a unique opportunity to interact with scientific and business colleagues across many functional areas, including Research, Translational Sciences, Regulatory Affairs, and Clinical Sciences.

This SRA position will report to a Scientist II in the Assay Strategy and Development group and will have the opportunity to advance our most promising pipeline programs to treat rare genetic diseases.


  •           Leads the development and characterization of quantitative and semi-quantitative bioanalytical methods to support pharmacokinetic, pharmacodynamic, biomarkers, and immunogenicity assessments. Techniques may include (but are not limited to) ELISA, ligand binding assays, polymerase chain reaction (qPCR and ddPCR), single-cell sequencing, sequence-tagged molecular tracing, cell-based and ex vivo culture assays.
  • Develops new techniques or brings in new technologies to enhance the analytical capabilities of the group.
  • Presents results, conclusions, and implications to bioanalytical and project teams.
  • Documents all experimental procedures and data in electronic lab notebook.
  • Shares responsibility for lab management duties.
  • Participates in internal and external development and validation of a variety of bioanalytical methods to detect drug, antibodies to protein therapeutics, and biomarkers in biological matrices.
  • Maintains awareness of industry guidance and standards for assay validation and performance.
  • Participates in technology and process transfers between groups and vendors.
  • Authors, reviews, and contributes to non-clinical and clinical study protocols.
  • Authors and reviews reports and documents such as validation protocols, validation reports, and sample analysis reports.
  • Independently carries out the aforementioned tasks and plans, implements, and completes projects with minimal supervision.
  • Participates in departmental and external scientific meetings and contributes to original peer-reviewed publications
  • Other duties as assigned.

Education & Experience

  • Bachelor’s degree and at least 6 years of experience; Master’s degree with at least 4 years of relevant experience 
  • Broad technical proficiency.
  • Familiar with, or willingness to learn relevant GLP, GxP, and other FDA guidances.
  • Excellent verbal and written communication skills: ability to cogently prepare and present data in group settings, prepare formal reports, give and receive useful feedback.
  • Ability to use computers effectively for data analysis and presentation.
  • Demonstrated experience initiating new methods or technologies in an experimental laboratory setting.

We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.


BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert